Alnylam Pharmaceuticals | ALNY - 贷款资金

股票价格

323.91

每天变化

-3.34 -1.02%

每月一次

0.47%

每年

43.15%

Q2 预测

309.25

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 41.47B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	贷款资金	更改		日
Acadia Pharmaceuticals	USD 0		0	2025-03
Agios Pharmaceuticals	USD 1.06M		0	2022-09
Alnylam Pharmaceuticals	USD 2.48B		1.44B	2025-12
Amgen	USD 50B		2.43B	2025-12
Arrowhead Research	USD 538.1M		323.22M	2025-12
BioCryst Pharmaceuticals	USD 428.67M		234.31M	2025-12
BioMarin Pharmaceutical	USD 597.18M		513K	2025-12
Incyte	USD 30.2M		5.17M	2025-12
Ionis Pharmaceuticals	USD 1.9B		1.87B	2025-12
Moderna	USD 610M		584M	2025-12
Neurocrine Biosciences	USD 169.5M		500K	2023-03
Novartis	USD 29.59B		5.35B	2025-12
PTC Therapeutics	USD 2.03B		193.22M	2025-12
Regeneron Pharmaceuticals	USD 2.71B		720.4M	2025-12
Sangamo BioSciences	USD 0		0	2022-06
Sanofi	EUR 15.72B		150.06M	2025-12
Sarepta Therapeutics	USD 828.97M		206.17M	2025-12
Takeda	JPY 4.27T		81.29B	2025-12
Tectonic Therapeutic	USD 43K		57K	2025-12
Ultragenyx Pharmaceutical	USD 763.74M		19.02M	2025-09
Vertex Pharmaceuticals	USD 111.4M		1.4M	2025-03
Xencor	USD 76.48M		11.29M	2025-12